Fintel reports that on February 11, 2025, Deutsche Bank initiated coverage of Denali Therapeutics (NasdaqGS:DNLI) with a Buy ...
Deutsche Bank initiated coverage of Denali Therapeutics (DNLI) with a Buy rating and $31 price target Maximize Your Portfolio with Data Driven ...
Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Denali Therapeutics (DNLI – Research Report) today and set a price target of ...